This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Myeloproliferative diseases
MYELOPROF
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
907 |
4. Check minimum number of eventsNone |
907 |
5. Include endpoints |
3178 |
6. Filter based on genotype QC (FinnGen only) |
3178 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF12
Myeloproliferative diseases
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3178 | 1659 | 1519 |
| Unadjusted period prevalence (%) | 0.62 | 0.57 | 0.67 |
| Median age at first event (years) | 63.29 | 61.79 | 64.93 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2604
- Matched controls
- 26041
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D47.3
ICD-10 Finland
Essential (haemorrhagic) thrombocythaemia
+∞
323.0
1154
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
122.4
323.0
1779
450
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
+∞
323.0
397
*
9962/3-C42.1
ICD-O-3
Essential thrombocythemia of bone marrow
+∞
323.0
361
*
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
+∞
323.0
305
*
D75.2
ICD-10 Finland
Essential thrombocytosis
564.7
323.0
612
14
D45
ICD-10 Finland
Polycythaemia vera
4145.4
323.0
1092
5
L01XX05
ATC
hydroxycarbamide; oral
2279.4
323.0
1392
13
9950/3-C42.1
ICD-O-3
Polycythemia vera of bone marrow
+∞
323.0
310
*
XW000
NOMESCO Finland
Bone marrow biopsy
28.0
323.0
880
466
TPH00
NOMESCO Finland
Phlebotomy
419.5
323.0
365
10
SPAT1074
SPAT
Venesection
164.4
255.1
266
18
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
34.8
228.5
300
97
L03AB05
ATC
interferon alfa-2b; parenteral
136.3
200.6
213
17
L01XX35
ATC
anagrelide; oral
1941.7
199.5
191
*
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
68.4
185.8
214
34
9961/3-C42.1
ICD-O-3
Primary myelofibrosis of bone marrow
947.4
182.6
177
*
189
Kela drug reimbursment
Imatinib
214.6
175.4
180
9
L01XE01
ATC
[U] imatinib; oral
184.2
150.4
156
9
M04AA01
ATC
allopurinol; systemic
3.8
139.6
708
2326
9960/3-C42.1
ICD-O-3
Myeloproliferative neoplasm, NOS, of bone marrow
+∞
136.7
130
*
9863/3-C42.1
ICD-O-3
Chronic myeloid leukemia, NOS, of bone marrow
+∞
131.4
125
*
B99
ICPC
Blood/lymph/spleen disease other
98.5
119.2
131
14
L03AB04
ATC
interferon alfa-2a; parenteral
162.6
118.3
124
8
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.5
107.7
591
2014
174
Kela drug reimbursment
Ruxolitinib
+∞
101.7
97
*
L01EA01
ATC
imatinib; oral (bcr-abl tyrosine kinase inhibitors)
316.7
90.4
91
*
374
Kela drug reimbursment
Ruxolitinib
+∞
88.0
84
*
316
Kela drug reimbursment
Imatinib
279.5
80.0
81
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.7
78.7
381
1149
D75.1
ICD-10 Finland
Secondary polycythaemia
32.4
77.7
103
33
212
Kela drug reimbursment
Gout
8.3
76.8
177
226
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
25.0
76.0
108
45
L01XE18
ATC
[U] ruxolitinib; oral
+∞
74.3
71
*
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
15.3
69.0
116
79
L01EJ01
ATC
ruxolitinib; oral
+∞
68.0
65
*
152
Kela drug reimbursment
Nilotinib
+∞
63.8
61
*
WW500
NOMESCO Finland
Blood transfusion
4.6
55.6
206
480
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
32.6
55.4
73
23
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
29.2
54.7
74
26
150
Kela drug reimbursment
Dasatinib
486.6
48.5
48
*
L01XX28
ATC
[D] imatinib; oral
+∞
47.0
45
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
45.4
1255
8828
L01XE06
ATC
[U] dasatinib; systemic
434.6
43.3
43
*
XX7BT
NOMESCO Finland
Radioactive phosphorus therapy
+∞
42.8
41
*
L01XE08
ATC
[U] nilotinib; oral
+∞
42.8
41
*
R79.8
ICD-10 Finland
Other specified abnormal findings of blood chemistry
14.6
41.8
71
50
R79.9
ICD-10 Finland
Abnormal finding of blood chemistry, unspecified
16.5
40.9
66
41
D75.0
ICD-10 Finland
Familial erythrocytosis
53.1
39.6
47
9
B03XA02
ATC
darbepoetin alfa; parenteral
6.1
39.3
110
186
B28
ICPC
Limited function/disability (B)
20.1
37.9
57
29
L03AA04
ATC
NA
26.2
35.4
49
19
B74
ICPC
Malignant neoplasm blood other
35.2
35.0
45
13
328
Kela drug reimbursment
Nilotinib
+∞
33.4
32
*
B04
ICPC
Blood symptom/complaint
18.5
33.1
51
28
L01EA03
ATC
nilotinib; oral
+∞
32.4
31
*
127
Kela drug reimbursment
Transplant complication
7.0
32.2
81
119
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
6.0
31.2
88
151
R50.9
ICD-10 Finland
Fever, unspecified
2.1
31.1
390
2006
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
7.4
29.5
71
98
B01AC14
ATC
[U] anagrelide; oral
+∞
29.2
28
*
D75.8
ICD-10 Finland
Other specified diseases of blood and blood-forming organs
64.7
28.0
32
5
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
15.8
27.7
45
29
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
13.2
27.4
48
37
324
Kela drug reimbursment
Dasatinib
+∞
27.1
26
*
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
50.5
25.3
30
6
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
12.0
25.2
46
39
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
25.1
765
5270
TPH00
SPAT
NA
+∞
25.0
24
*
2384A
ICD-9 Finland
Neoplasm of uncertain behaviour of other and unspecified sites and tissues, Polycythaemia vera
+∞
25.0
24
*
B01AB05
ATC
enoxaparin; parenteral
1.6
24.8
828
5837
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
29.4
24.1
32
11
A05AA02
ATC
ursodeoxycholic acid; oral
5.8
24.0
69
122
L01AB01
ATC
busulfan; systemic
+∞
24.0
23
*
C03CA01
ATC
furosemide; systemic
1.6
22.2
831
5995
D47.0
ICD-10 Finland
Histiocytic and mast cell tumours of uncertain and unknown behaviour
80.8
21.7
24
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.9
21.2
321
1763
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
11.0
21.1
40
37
B03XA01
ATC
erythropoietin; parenteral
7.1
20.9
51
73
C92.9
ICD-10 Finland
Myeloid leukaemia, unspecified
211.6
20.6
21
*
L01EA02
ATC
dasatinib; oral
211.6
20.6
21
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.1
19.9
228
1120
B75
ICPC
Neoplasm blood benign/unspecified
105.8
19.6
21
*
20899
ICD-8 Finland
Polycythaemia vera
+∞
18.8
18
*
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
4.0
18.5
75
193
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
30.3
18.3
24
8
R04.0
ICD-10 Finland
Epistaxis
2.1
18.3
215
1069
306
Kela drug reimbursment
Erythropoietin and darbepoetin
13.1
17.9
31
24
9875/3-C42.1
ICD-O-3
Chronic myelogenous leukemia, BCR/ABL positive of bone marrow
+∞
17.7
17
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.8
16.6
298
1730
D73.5
ICD-10 Finland
Infarction of spleen
16.4
16.5
26
16
L03AA02
ATC
filgrastim; parenteral
3.1
16.1
90
299
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.9
16.1
262
1473
WW200
NOMESCO Finland
Immunization
3.2
16.0
84
267
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
18.6
16.0
24
13
I81
ICD-10 Finland
Portal vein thrombosis
9.2
15.7
32
35
PH_2
NOMESCO Finland
Other procedures on veins
+∞
15.6
15
*
170
Kela drug reimbursment
Bosutinib
+∞
15.6
15
*
S97
ICPC
Chronic ulcer skin
2.3
15.6
154
707
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
38.3
15.4
19
5
D72.9
ICD-10 Finland
Disorder of white blood cells, unspecified
9.8
15.2
30
31
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
17.8
15.1
23
13
B01AA03
ATC
warfarin; systemic
1.5
14.9
567
4033
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
14.2
508
3560
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.8
14.0
90
328
J01MA12
ATC
levofloxacin; systemic
1.5
13.7
454
3127
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.0
13.7
185
974
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.2
13.6
135
621
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.2
13.5
142
672
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.1
13.1
153
758
I50.9
ICD-10 Finland
Heart failure, unspecified
1.6
12.6
373
2494
2387X
ICD-9 Finland
Neoplasm of uncertain behaviour of other and unspecified sites and tissues, Other lymphatic and haematopoietic tissues[STATUS LYMPHO- ET MYELOPROLIFERATIVUS NUD]
70.2
12.6
14
*
D64.9
ICD-10 Finland
Anaemia, unspecified
1.7
12.5
263
1603
2387B
ICD-9 Finland
Neoplasm of uncertain behaviour of other and unspecified sites and tissues, Other lymphatic and haematopoietic tissues[THROMBOCYTHAEMIA IDIOPATHICA]
+∞
12.5
12
*
D69.1
ICD-10 Finland
Qualitative platelet defects
24.4
12.5
17
7
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
3.0
12.4
72
248
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.0
12.2
163
850
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.5
12.1
411
2839
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.5
12.0
539
3948
L04AD01
ATC
ciclosporin; systemic
3.3
11.9
59
182
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.7
11.8
250
1528
SPAT1088
SPAT
Blood transfusion
7.4
11.7
27
37
B73
ICPC
Leukaemia
16.5
11.7
18
11
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
12.6
11.6
20
16
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
5.5
11.5
33
61
L01XE14
ATC
[U] bosutinib; oral
+∞
11.5
11
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.5
11.4
428
3023
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
25.1
11.1
15
6
A02BC02
ATC
pantoprazole; systemic
1.3
11.1
1543
13599
ZX120
NOMESCO Finland
Intravenous
1.7
11.0
233
1423
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.4
11.0
88
368
M10.9
ICD-10 Finland
Gout, unspecified
1.9
10.9
169
935
C90.0
ICD-10 Finland
Multiple myeloma
3.5
10.8
48
137
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.7
10.8
210
1250
D68.8
ICD-10 Finland
Other specified coagulation defects
5.2
10.7
32
62
D47.7
ICD-10 Finland
Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
21.5
10.7
15
7
D75
ICD-10 Finland
Other diseases of blood and blood-forming organs
60.2
10.6
12
*
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.2
10.6
102
466
121
Kela drug reimbursment
Severe hypofunction of sexual glands
3.1
10.5
57
189
TPH04
NOMESCO Finland
Cathetrisation of vein
1.4
10.4
489
3606
B86
ICPC
OTHER HAEMATOLOGICAL ABNORMALITY
110.4
10.4
11
*
360
Kela drug reimbursment
Bosutinib
+∞
10.4
10
*
2387A
ICD-9 Finland
Neoplasm of uncertain behaviour of other and unspecified sites and tissues, Other lymphatic and haematopoietic tissues[MYELOFIBROSIS]
+∞
10.4
10
*
J01MA14
ATC
moxifloxacin; systemic
1.7
10.4
203
1210
C95.9
ICD-10 Finland
Leukaemia, unspecified
18.8
10.3
15
8
J01DB01
ATC
cefalexin; oral
1.3
10.2
1913
17511
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
1.9
9.9
143
772
H02AB06
ATC
prednisolone; systemic
1.3
9.7
1075
9100
XW000
SPAT
NA
55.2
9.6
11
*
R71
ICD-10 Finland
Abnormality of red blood cells
11.4
9.6
17
15
R72
ICD-10 Finland
Abnormality of white blood cells, not elsewhere classified
8.4
9.5
20
24
D46.2
ICD-10 Finland
Refractory anaemia with excess of blasts [RAEB]
17.6
9.4
14
8
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
4.3
9.4
33
77
2051A
ICD-9 Finland
Myeloid leukaemia, Chronic
+∞
9.4
9
*
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.7
9.1
226
3298
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.4
9.0
586
4568
I82.0
ICD-10 Finland
Budd-Chiari syndrome
24.1
8.9
12
5
C07AB07
ATC
bisoprolol; oral
1.3
8.9
1175
10151
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.6
8.8
266
1780
K99
ICPC
Cardiovascular disease other
2.2
8.8
82
372
R16.1
ICD-10 Finland
Splenomegaly, not elsewhere classified
9.5
8.8
17
18
V03AC03
ATC
deferasirox; oral
50.1
8.7
10
*
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.5
8.7
270
1821
C03DA01
ATC
spironolactone; oral
1.5
8.6
263
1769
I67.6
ICD-10 Finland
Nonpyogenic thrombosis of intracranial venous system
16.3
8.5
13
8
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.4
8.4
358
2586
C94.5
ICD-10 Finland
Acute myelofibrosis
+∞
8.3
8
*
L01EA04
ATC
bosutinib; oral
+∞
8.3
8
*
D47
ICD-10 Finland
Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
+∞
8.3
8
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.5
8.3
337
2409
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.5
8.3
254
1708
A07AA02
ATC
nystatin; oral
1.8
8.3
148
863
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
2.5
8.2
60
240
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
2.2
8.2
81
379
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
1.7
8.1
165
1001
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
2.8
8.0
49
179
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.2
7.9
28
67
D73.1
ICD-10 Finland
Hypersplenism
13.1
7.9
13
10
N02AX02
ATC
tramadol; systemic, rectal
1.3
7.8
964
8205
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
2.5
7.7
58
239
D58.2
ICD-10 Finland
Other haemoglobinopathies
25.1
7.6
10
*
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
2.0
7.5
94
485
B59
ICPC
Blood and Immunity, Other therap proced/minor surg NEC
80.3
7.4
8
*
WW304
NOMESCO Finland
Transfer of stem cells from registered domestic donator
80.3
7.4
8
*
C92.2
ICD-10 Finland
Atypical chronic myeloid leukaemia, BCR/ABL- negative
+∞
7.3
7
*
373
Kela drug reimbursment
Ponatinib
+∞
7.3
7
*
H02AB09
ATC
hydrocortisone; systemic
2.5
7.3
52
208
O99.1
ICD-10 Finland
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
9.4
7.3
14
15
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
4.9
7.3
22
45
Y84
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.6
7.3
31
88
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.7
7.3
162
1006
-69
ICPC
Other reason for encounter NEC
2.0
7.2
92
478
A46
ICD-10 Finland
Erysipelas
1.4
7.2
320
2330
AA1AD
NOMESCO Finland
CT of head and brain
1.3
7.0
555
4438
D46.0
ICD-10 Finland
Refractory anaemia without ring sideroblasts, so stated
10.0
7.0
13
13
JMA11
NOMESCO Finland
Laparoscopic total splenectomy
10.0
7.0
13
13
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
2.7
7.0
45
168
N02AA05
ATC
oxycodone; systemic
1.4
6.9
343
2541
L04AA01
ATC
[U] ciclosporin; systemic
2.8
6.9
41
148
JCA22
NOMESCO Finland
Endoscopic ligature of oesophageal varices
6.7
6.8
16
24
M01AE01
ATC
ibuprofen; systemic, rectal
0.8
6.7
1828
19508
C92.7
ICD-10 Finland
Other myeloid leukaemia
22.6
6.7
9
*
DKW00
NOMESCO Finland
Cauterisation of mucosa of nose
3.3
6.7
31
95
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
2.3
6.6
56
243
J02AC03
ATC
voriconazole; systemic
7.8
6.6
14
18
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
12.3
6.6
11
9
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.5
6.5
219
1508
R51.80
ICD-10 Finland
Headache
1.4
6.4
260
1855
C92.5
ICD-10 Finland
Acute myelomonocytic leukaemia
70.0
6.4
7
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.4
6.4
367
2794
L04AA06
ATC
mycophenolic acid; systemic
2.8
6.4
38
138
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.4
6.3
312
2311
L01XE24
ATC
[U] ponatinib; oral
+∞
6.3
6
*
R89.8
ICD-10 Finland
Abnormal findings in specimens from other organs, systems and tissues, other abnormal findings
26.7
6.2
8
*
B83
ICPC
Purpura/coagulation defect
26.7
6.2
8
*
XQ848
NOMESCO Finland
Dermatological photography
2.1
6.2
64
306
K93
ICPC
Pulmonary embolism
3.2
6.2
30
95
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.6
6.2
142
894
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.5
6.2
174
1150
9989/3-C42.1
ICD-O-3
Myelodysplastic syndrome, NOS, of bone marrow
7.7
6.1
13
17
R60.0
ICD-10 Finland
Localized oedema
1.4
6.1
246
1758
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
2.1
6.0
60
283
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
2635
15131
5.34
314.19
22.2
8.6
5.2
4.2
e9/l
21.21
2468
13129
849
409
27.96
307.65
1.3
1.2
29.7
45.3
u/l
0.88
703
356
2498
12175
5.92
307.65
18.1
6.0
8.4
8.8
%
8.88
2432
11318
2498
12125
5.95
307.65
17.2
5.7
2.7
2.9
%
2.41
2431
11225
2558
12952
6.00
307.65
15.5
5.5
0.1
0.0
e9/l
71.11
2372
11094
857
2024
5.43
307.65
9.8
3.7
1.2
0.5
%
8.00
319
462
2565
13220
5.87
307.65
15.8
5.6
2.0
1.9
e9/l
0.25
2417
11515
2586
13389
6.00
307.65
17.0
5.7
0.2
0.2
e9/l
5.53
2415
11623
2475
11807
5.96
307.65
17.0
5.8
1.0
0.7
%
83.58
2404
10947
2553
12890
5.99
307.65
15.5
5.5
0.6
0.6
e9/l
1.41
2368
11026
853
2127
5.11
307.65
10.1
3.9
0.2
0.1
%
3.39
419
603
2507
12437
5.81
307.65
17.7
5.9
24.9
27.1
%
18.29
2439
11501
925
229
56.57
307.65
1.1
1.1
—
—
—
0
0
1422
3261
7.08
307.65
4.2
2.4
1.9
1.8
%
2.60
1274
2863
776
441
22.96
307.65
1.5
1.5
—
—
—
0
0
1202
2433
7.34
307.65
4.0
2.5
77.9
68.9
e9/l
11.31
899
1866
1847
7050
4.87
307.65
4.8
2.7
1534.0
5866.3
umol/l
8.09
1720
6016
2099
3156
17.64
307.65
10.0
3.8
282.5
243.4
u/l
14.67
2042
2955
2475
12249
5.61
307.65
16.0
5.7
60.6
57.8
%
25.42
2399
11377
1138
3741
4.18
303.08
2.8
2.6
22.5
22.3
%
0.10
1002
3182
1156
3994
3.98
284.31
2.7
2.5
2.4
2.3
g/l
10.15
1097
3685
1203
4299
3.89
281.20
2.8
2.5
13.1
12.6
umol/l
1.45
1144
3970
396
703
6.29
217.27
2.7
2.4
3.3
3.6
g/l
4.53
376
667
2324
14096
3.41
209.85
10.7
6.2
12.2
11.7
umol/l
0.91
2263
13340
299
460
7.07
187.94
8.7
3.2
1.8
1.4
%
1.05
231
349
1833
10591
2.73
163.70
4.0
2.8
160.4
141.9
ug/l
0.85
1709
9664
148
5
312.53
146.88
7.3
1.0
—
—
—
0
0
470
1336
3.95
144.52
1.8
1.8
1.1
1.5
g/l
19.40
404
1146
1858
11417
2.51
136.60
21.7
9.7
0.1
0.0
e9/l
4.23
1663
9304
77
20
39.43
125.91
1.0
1.0
—
—
—
0
0
311
738
4.56
120.98
2.4
2.1
93.0
89.6
%
1.82
272
704
187
290
6.79
115.88
9.1
3.2
65.3
56.8
%
3.57
109
178
1278
7049
2.36
113.67
2.7
2.2
4.8
3.0
mg/l
21.97
1101
5961
248
517
5.12
112.65
5.6
3.5
61.1
57.6
%
3.03
248
517
2042
13899
2.31
107.75
8.8
6.8
1.2
1.2
mmol/l
0.08
1726
11650
2670
20575
2.86
105.85
16.4
7.6
84.0
79.4
u/l
4.86
2603
19304
280
710
4.23
99.51
1.9
1.5
—
—
—
0
0
752
3634
2.40
86.64
5.9
5.6
1.0
1.0
mmol/l
0.27
711
3348
1834
12622
2.07
84.97
8.0
6.0
1.2
1.2
mmol/l
4.24
1691
11342
836
4500
2.16
72.71
4.6
3.2
0.8
0.8
mmol/l
1.54
797
4181
238
685
3.67
70.33
2.8
2.4
175.7
196.5
%
2.83
229
651
190
477
4.17
68.03
7.3
5.2
868.5
669.5
iu/ml
0.16
26
69
226
656
3.63
65.87
3.5
2.9
1.4
1.6
mg/l
6.46
218
589
1695
11984
1.89
65.51
6.5
4.7
35.5
35.1
g/l
2.79
1597
11110
95
134
7.28
64.03
7.2
3.1
—
—
—
0
0
1094
6750
1.95
63.83
1.8
1.6
20.2
20.5
nmol/l
0.23
970
5690
598
2957
2.26
63.24
5.3
2.6
7.0
8.7
umol/l
1.75
544
2580
1634
11554
1.85
61.75
2.4
2.0
91.5
94.2
pmol/l
1.57
1013
5864
435
1892
2.51
61.45
2.8
2.8
10.0
10.6
g/l
1.51
397
1711
516
2440
2.33
60.45
2.7
2.6
66.5
66.3
g/l
0.19
472
2216
1083
6804
1.90
58.78
5.7
3.9
84.1
87.9
%
4.64
1026
6635
2065
16017
1.83
54.56
5.9
4.7
6.6
6.8
mmol/l
5.31
1991
15050
750
4272
1.99
53.73
2.9
2.0
31.8
29.9
s
10.72
708
4141
352
1488
2.54
52.44
1.9
1.9
1.5
1.4
g/l
0.17
319
1341
146
375
4.03
50.58
3.1
2.6
217.0
2329.7
u/ml
—
8
28
894
5682
1.80
44.27
2.0
1.7
1.2
1.4
mg/l
1.06
698
4382
2330
19380
1.76
41.68
5.3
4.2
12.1
13.3
mm/h
2.87
2188
17816
49
54
9.20
40.42
1.6
1.3
—
—
—
0
0
863
5565
1.76
39.97
1.9
1.8
1108.0
1177.7
nmol/l
1.44
666
4139
75
144
5.31
37.19
1.7
1.5
—
—
—
0
0
75
144
5.31
37.19
1.7
1.5
—
—
—
0
0
225
924
2.54
35.27
3.3
3.4
1.6
1.7
ratio
0.01
22
73
229
952
2.51
34.98
3.3
3.4
54.2
119.9
mg/l
0.54
201
766
229
952
2.51
34.98
3.3
3.4
36.9
68.5
mg/l
1.31
202
768
1503
11567
1.57
32.90
12.7
10.1
1.4
1.3
inr
1.15
477
3242
253
1150
2.30
31.64
2.8
2.4
3.5
3.8
g/l
2.56
175
831
253
1151
2.30
31.57
2.8
2.4
—
—
—
0
0
253
1152
2.30
31.51
2.8
2.4
6.9
7.4
g/l
3.81
180
869
125
399
3.22
31.25
1.3
1.4
152.5
119.8
u/ml
0.39
22
79
238
1076
2.31
30.12
2.8
2.4
11.0
10.3
g/l
1.31
190
915
237
1075
2.30
29.76
2.9
2.5
3.2
3.1
g/l
0.67
175
850
125
427
3.01
27.86
1.2
1.2
—
—
—
0
0
84
225
3.81
27.48
1.5
1.8
3.1
4.5
mg/l
4.05
79
219
166
667
2.57
27.18
2.3
1.5
—
—
—
0
0
216
988
2.27
26.55
3.1
2.5
1.3
1.0
g/l
0.58
186
854
432
2548
1.80
25.99
6.0
7.1
9.9
10.4
mmol/l
0.89
408
2417
159
645
2.54
25.53
2.5
1.6
—
—
—
0
0
194
864
2.33
25.38
3.1
2.3
0.0
0.0
g/l
0.06
173
794
1092
8179
1.51
24.97
4.6
3.2
33.6
38.7
u/l
1.10
1045
7742
699
4745
1.61
24.82
2.3
1.8
—
—
—
0
0
131
491
2.74
24.64
2.5
1.6
—
—
—
0
0
181
797
2.35
24.30
3.0
2.3
0.0
0.0
g/l
0.00
162
741
1148
8726
1.49
24.27
3.4
3.1
2203.8
1557.2
ng/l
2.12
1009
7518
182
808
2.33
23.98
3.0
2.3
0.0
0.0
g/l
0.00
162
742
197
905
2.25
23.95
2.9
2.2
38.6
37.6
g/l
1.42
168
781
397
2344
1.79
23.68
3.3
3.9
1.2
1.2
mmol/l
2.38
344
2038
357
2046
1.84
23.48
2.0
1.6
—
—
—
0
0
64
159
4.09
23.26
3.9
2.0
2275.4
698.2
e6/l
0.44
28
71
663
4522
1.59
22.84
1.5
1.5
2.3
2.6
g/l
1.72
426
2661
111
397
2.86
22.81
1.2
1.2
315.8
268.8
u/ml
0.75
74
243
35
53
6.67
22.12
6.1
2.6
43.2
36.4
u/l
0.36
17
16
23
22
10.52
20.90
1.3
1.5
—
—
—
0
0
2781
25642
1.68
20.19
27.8
15.6
20.1
25.4
mg/l
16.75
2421
20647
58
149
3.95
20.18
4.2
2.0
1201.2
553.2
e6/l
0.50
48
127
83
271
3.12
20.06
3.0
1.6
—
—
—
0
0
56
142
4.00
19.84
4.4
2.0
0.2
0.2
e9/l
0.21
49
127
36
66
5.51
18.83
1.3
1.1
72.2
88.4
%
1.89
21
37
54
141
3.88
18.39
3.6
1.6
—
—
—
0
0
54
141
3.88
18.39
3.6
1.6
—
—
—
0
0
54
141
3.88
18.39
3.6
1.6
—
—
—
0
0
54
141
3.88
18.39
3.6
1.6
—
—
—
0
0
83
292
2.89
17.64
3.0
1.6
—
—
—
0
0
35
67
5.27
17.49
1.3
1.4
77.9
85.2
%
0.41
21
39
108
438
2.52
17.41
1.3
1.2
—
—
—
0
0
73
243
3.05
17.12
3.0
1.5
—
—
—
0
0
73
243
3.05
17.12
3.0
1.5
—
—
—
0
0
73
243
3.05
17.12
3.0
1.5
—
—
—
0
0
45
109
4.17
16.98
4.0
1.7
—
—
—
0
0
45
109
4.17
16.98
4.0
1.7
—
—
—
0
0
45
111
4.10
16.58
4.0
1.7
—
—
—
0
0
47
121
3.93
16.35
1.7
2.5
83.2
96.0
%
1.49
42
115
222
1227
1.87
16.27
2.1
1.9
1.4
2.5
ug/l
1.02
200
1070
51
140
3.69
16.21
2.0
2.7
34.8
39.3
%
0.37
13
51
56
165
3.44
16.03
2.1
2.0
16.3
14.4
%
0.30
23
63
2309
20777
1.41
15.77
38.7
18.8
15.6
13.8
%
170.92
2293
20278
2619
24139
1.48
15.49
5.1
4.1
1.3
1.3
mmol/l
1.40
2468
21711
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
189
1010
1.93
15.36
3.8
3.0
0.4
0.4
u/ml
0.03
112
580
1066
8513
1.38
15.33
2.5
2.1
140.4
221.7
u/l
4.39
1003
7943
1477
12421
1.35
15.26
7.8
4.1
—
—
—
0
0
364
2356
1.62
15.16
2.1
2.2
398.6
370.4
nmol/l
1.58
337
2135
1171
9509
1.37
15.12
3.6
3.4
2.3
2.4
mmol/l
3.93
1022
8165
1058
8465
1.37
14.95
2.9
2.6
54.0
58.3
u/l
3.48
972
7777
39
94
4.19
14.84
1.3
1.4
—
—
—
0
0
130
619
2.15
14.52
1.2
1.3
—
—
—
0
0
1040
8358
1.36
14.10
3.8
3.3
57.5
86.3
e6/l
0.72
822
6476
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
24
41
5.89
13.52
1.3
1.2
78.3
70.5
%
0.32
12
13
24
41
5.89
13.52
1.3
1.2
77.7
75.4
%
0.09
12
14
275
1707
1.67
13.49
3.9
3.6
1.8
1.9
mmol/l
0.20
197
1256
286
1798
1.65
13.35
3.9
3.6
5.2
5.2
kpa
0.10
256
1653
841
6586
1.38
13.26
5.1
2.3
—
—
—
0
0
468
3302
1.49
13.14
2.0
1.8
—
—
—
0
0
467
3312
1.48
12.76
2.0
1.7
—
—
—
0
0
59
207
2.89
12.69
1.7
1.6
—
—
—
0
0
102
466
2.23
12.66
1.6
1.4
—
—
—
0
0
80
330
2.46
12.53
1.0
1.1
—
—
—
0
0
40
112
3.60
12.42
1.6
2.5
1489.1
1239.4
u/ml
0.19
40
112
20
31
6.49
12.36
1.3
1.8
—
—
—
0
0
81
339
2.43
12.30
1.2
1.2
2.1
3.9
u/ml
0.83
30
105
950
7662
1.34
12.20
3.7
3.2
0.5
0.5
e6/l
0.01
739
5836
280
1791
1.62
12.19
1.7
1.7
—
—
—
0
0
693
5324
1.39
12.13
3.4
3.1
2.4
2.5
mmol/l
1.64
608
4670
79
330
2.43
12.06
1.2
1.2
4.8
5.4
u/ml
0.12
38
139
69
271
2.58
11.99
1.2
1.2
52.8
57.2
u/l
0.29
45
188
133
692
1.96
11.74
1.5
1.5
0.2
0.2
g/l
1.10
121
655
49
162
3.06
11.72
1.9
1.9
—
—
—
0
0
1479
12742
1.30
11.69
5.2
5.2
0.0
0.0
estimate
0.50
392
2395
381
2646
1.50
11.49
2.2
2.1
0.2
0.2
g/l
0.69
342
2452
748
5873
1.36
11.32
3.0
2.6
4.8
5.3
e6/l
0.54
675
5162
1492
12904
1.29
11.31
3.9
3.9
0.0
0.0
estimate
1.08
389
2325
171
977
1.79
11.30
2.4
2.2
265.7
745.1
ug/l
1.49
163
918
1811
16064
1.30
11.30
3.7
3.2
61.2
52.9
u/l
2.99
1713
14738
135
717
1.92
11.23
1.5
1.5
1.1
1.2
g/l
1.46
125
677
1473
12729
1.29
11.20
3.9
3.8
0.0
0.0
estimate
0.00
400
2364
1268
10752
1.30
11.12
4.3
3.9
45.3
99.5
ng/l
0.72
997
7869
173
997
1.78
11.10
2.6
2.7
—
—
—
0
0
126
657
1.96
11.07
1.8
1.9
15.9
11.9
mg/l
1.23
109
603
67
272
2.49
10.90
2.9
2.8
—
—
—
0
0
83
376
2.24
10.57
1.5
1.4
—
—
—
0
0
73
316
2.34
10.35
1.6
1.6
—
—
—
0
0
29
74
3.95
10.29
6.8
2.1
—
—
—
0
0
2822
26825
1.46
10.23
29.2
18.3
139.4
139.6
mmol/l
3.62
2779
26128
255
1666
1.58
10.15
6.9
7.0
24.7
24.9
mmol/l
0.28
255
1656
42
139
3.05
10.07
1.1
1.1
118.8
83.4
u/l
1.53
30
102
1141
9639
1.29
10.00
4.3
3.8
113.8
117.3
e6/l
0.05
865
6935
23
50
4.63
10.00
1.6
1.3
—
—
—
0
0
42
140
3.03
9.95
1.1
1.1
39.7
26.1
u/l
0.93
31
100
2824
26888
1.45
9.74
30.9
18.5
4.0
4.0
mmol/l
6.13
2776
26150
229
1474
1.60
9.72
2.8
3.2
4.4
4.4
pmol/l
0.16
187
1280
150
863
1.77
9.72
1.4
1.2
—
—
—
0
0
72
320
2.28
9.63
1.0
1.1
111.7
115.8
%
0.48
66
291
1271
10933
1.27
9.49
2.6
2.2
78.3
78.6
nmol/l
0.15
1135
9623
2126
19457
1.28
9.40
4.3
4.0
15.1
14.9
pmol/l
1.96
1949
17466
82
391
2.13
9.25
1.6
1.5
—
—
—
0
0
181
1114
1.66
9.20
2.1
1.8
—
—
—
0
0
2505
23451
1.32
9.15
5.3
4.8
2.0
2.1
mu/l
0.29
2345
21172
20
42
4.79
9.06
1.3
1.5
—
—
—
0
0
56
229
2.47
9.03
1.3
1.2
—
—
—
0
0
85
416
2.07
8.97
1.6
1.4
—
—
—
0
0
192
1210
1.62
8.90
2.9
1.9
—
—
—
0
0
114
626
1.85
8.64
1.6
1.5
—
—
—
0
0
397
2932
1.40
8.57
3.8
3.6
—
—
—
0
0
76
365
2.11
8.45
1.5
1.4
—
—
—
0
0
2577
24293
1.32
8.44
26.6
14.7
76.0
76.9
ml/min/173m2
1.27
2275
20127
26
71
3.68
8.44
1.0
1.2
—
—
—
0
0
2638
24952
1.34
8.44
5.6
4.6
1.3
1.5
mmol/l
60.20
2495
22645
2656
25161
1.34
8.30
5.6
4.6
4.2
4.6
mmol/l
81.16
2530
22995
310
2203
1.45
8.28
3.2
2.7
56.5
62.8
ml/min/173m2
2.96
184
914
110
607
1.84
8.22
2.6
2.5
16.3
16.0
%
0.20
56
312
17
34
5.02
8.13
1.1
1.4
8.9
282148.8
nmol/l
0.49
12
28
39
142
2.77
7.96
1.1
1.1
—
—
—
0
0
22
56
3.95
7.87
1.1
1.1
—
—
—
0
0
114
647
1.79
7.80
4.6
4.8
5.0
5.1
kpa
0.21
114
638
1127
9732
1.24
7.67
4.2
4.1
—
—
—
0
0
111
631
1.79
7.56
2.9
2.9
7.7
7.9
kpa
1.02
105
578
433
3326
1.35
7.30
7.2
7.0
5.0
5.1
kpa
1.92
415
3164
433
3326
1.35
7.30
7.2
7.0
11.9
12.0
kpa
0.12
413
3164
169
1090
1.58
7.17
4.4
4.0
24.4
24.9
mmol/l
1.08
152
1004
303
2204
1.41
7.12
3.5
3.8
88.5
94.1
ng/l
0.55
261
1872
358
2690
1.37
6.94
3.7
3.5
5.8
5.9
kpa
0.57
348
2608
1916
17602
1.22
6.91
5.1
4.8
2824.6
2217.4
e6/l
0.09
23
272
21
57
3.70
6.91
1.8
1.3
—
—
—
0
0
356
2679
1.37
6.84
3.7
3.5
1.7
2.0
mmol/l
0.92
291
2150
823
6935
1.25
6.81
4.2
4.3
0.0
0.0
estimate
0.88
381
2284
331
2467
1.38
6.75
2.4
2.5
32.6
57.8
u/l
0.71
288
2116
145
918
1.61
6.67
1.2
1.2
0.2
1.0
u/ml
—
8
80
427
3317
1.33
6.66
7.4
7.0
1.1
1.1
mmol/l
0.05
330
2583
2826
27191
1.35
6.61
23.6
10.9
25.4
25.9
u/l
1.00
2770
26110
41
171
2.42
6.44
1.5
1.5
10.4
6.7
u/l
0.21
21
83
336
2531
1.37
6.41
6.5
6.5
1.5
1.4
mmol/l
0.78
324
2439
2692
25748
1.30
6.39
6.1
5.2
2.4
2.7
mmol/l
58.13
2556
23400
121
743
1.65
6.30
3.1
3.2
25.1
25.1
mmol/l
0.00
112
641
164
1084
1.54
6.28
1.7
1.8
39.9
38.5
u/l
0.36
136
946
669
5551
1.26
6.27
4.1
3.9
592.9
584.2
ng/l
0.01
544
4551
9
5
18.04
6.26
1.0
1.0
—
—
—
0
0
43
187
2.32
6.17
1.1
1.2
125.0
115.3
titre
—
6
34
490
3942
1.29
5.89
32.0
26.7
1.5
1.4
inr
0.81
77
555
213
1522
1.43
5.57
8.5
9.0
24.4
24.4
mmol/l
0.01
203
1424
37
158
2.36
5.56
1.3
1.1
103.5
82.1
u/l
0.50
32
139
61
318
1.94
5.54
1.1
1.4
292.2
291.6
pmol/l
0.00
48
244
449
3613
1.28
5.37
7.8
6.6
104.0
104.2
mmol/l
0.50
442
3527
2521
24044
1.23
5.36
6.4
6.2
38.5
40.4
mmol/mol
23.17
2375
22020
63
336
1.89
5.36
1.3
1.4
113387.5
92817.7
e6/l
0.14
38
198
535
4420
1.25
5.13
3.4
3.0
1.8
2.4
e6/l
1.33
283
2432
113
721
1.59
5.11
1.7
1.7
—
—
—
0
0
8
6
13.36
5.08
2.0
1.0
—
—
—
0
0
31
128
2.44
5.04
1.1
1.1
—
—
—
0
0
21
72
2.93
4.87
1.3
1.2
—
—
—
0
0
2385
22687
1.21
4.86
33.1
16.7
39.0
39.2
%
0.42
1516
15159
186
1333
1.42
4.82
4.3
3.7
24.1
24.2
mmol/l
0.13
175
1191
31
131
2.38
4.81
1.9
1.3
—
—
—
0
0
31
131
2.38
4.81
1.9
1.3
—
—
—
0
0
38
177
2.16
4.71
1.7
1.3
—
—
—
0
0
66
378
1.76
4.53
1.3
1.4
1913.2
1808.7
e6/l
0.08
46
274
27
111
2.44
4.46
2.0
1.2
—
—
—
0
0
114
1684
0.66
4.43
1.8
1.8
—
—
—
0
0
43
217
2.00
4.36
1.0
1.1
—
—
—
0
0
10
22
4.56
4.30
1.0
1.0
—
—
—
0
0
12
31
3.88
4.25
1.4
1.0
—
—
—
0
0
112
748
1.52
4.20
1.5
1.6
0.6
8.6
iu/ml
0.54
20
160
36
175
2.07
4.05
1.8
1.3
—
—
—
0
0
90
580
1.57
3.98
2.2
2.9
36.9
37.0
umol/l
0.01
72
484
116
792
1.48
3.94
1.9
1.7
—
—
—
0
0
61
358
1.72
3.89
2.6
1.4
—
—
—
0
0
2603
25107
1.20
3.89
5.2
4.9
6.0
6.0
mmol/l
0.82
2381
22606
21
82
2.57
3.88
2.1
1.9
—
—
—
0
0
280
2214
1.29
3.86
3.0
2.9
4.6
4.6
kpa
0.18
273
2141
60
352
1.72
3.84
2.6
1.4
—
—
—
0
0
32
152
2.12
3.84
1.3
1.2
20.7
16.6
u/l
0.48
27
131
43
228
1.90
3.82
1.1
1.1
—
—
—
0
0
164
1201
1.39
3.81
4.6
5.3
1.9
1.6
%
1.46
152
1123
9
15
6.01
3.81
3.0
4.9
—
—
—
0
0
43
773
0.55
3.81
1.6
1.7
5.5
3.6
mg/l
0.35
38
551
11
29
3.80
3.80
1.5
1.0
—
—
—
0
0
61
361
1.70
3.79
2.6
1.4
—
—
—
0
0
320
2582
1.27
3.76
3.5
3.0
224.0
220.7
ng/l
0.05
296
2351
27
122
2.22
3.67
1.2
1.2
—
—
—
0
0
335
2737
1.25
3.55
8.4
7.8
118.2
121.2
g/l
1.43
324
2637
108
744
1.47
3.54
1.7
1.8
—
—
—
0
0
8
13
6.17
3.50
1.0
1.5
—
—
—
0
0
25
113
2.22
3.41
1.5
5.8
—
61.7
—
0
27
52
305
1.72
3.37
1.1
1.1
—
—
—
0
0
58
352
1.66
3.32
2.7
1.4
—
—
—
0
0
74
478
1.56
3.30
1.6
1.3
12.7
10.3
u/l
0.80
66
385
548
4739
1.19
3.29
3.2
2.8
0.9
1.2
e6/l
1.09
297
2730
58
354
1.65
3.26
2.7
1.4
—
—
—
0
0
214
1674
1.30
3.24
1.7
1.5
—
—
—
0
0
61
378
1.63
3.24
1.3
1.3
0.2
0.4
nmol/l
—
5
25
337
2785
1.23
3.23
2.2
2.2
190.5
155.5
ug/g
0.56
268
2169
58
357
1.64
3.17
2.6
1.4
—
—
—
0
0
20
85
2.36
3.15
1.3
1.5
—
2024630.0
—
0
5
33
172
1.93
3.14
1.1
1.1
—
—
—
0
0
65
413
1.59
3.13
1.2
1.2
—
—
—
0
0
12
39
3.08
3.09
1.1
1.2
—
—
—
0
0
85
579
1.48
3.00
1.4
1.3
—
—
—
0
0
50
301
1.67
2.99
3.4
3.7
—
—
—
0
0
78
526
1.50
2.90
1.1
1.2
—
9.2
—
0
6
91
633
1.45
2.90
2.2
2.2
131.3
127.9
g/l
0.41
70
459
89
617
1.46
2.89
1.6
1.3
—
—
—
0
0
89
617
1.46
2.89
1.6
1.3
—
—
—
0
0
90
628
1.45
2.83
1.2
1.2
1.8
3.8
u/ml
—
5
59
28
144
1.95
2.79
1.0
1.0
—
—
—
0
0
91
638
1.44
2.79
1.2
1.2
3.9
7.6
u/ml
—
8
112
83
572
1.46
2.79
1.4
1.6
—
—
—
0
0
155
1189
1.32
2.75
4.8
5.3
0.9
0.9
%
0.64
143
1114
1494
14023
1.12
2.72
2.7
2.6
—
—
—
0
0
13
48
2.72
2.71
2.5
1.1
—
—
—
0
0
15
60
2.51
2.70
1.0
1.8
—
—
—
0
0
75
513
1.47
2.63
1.2
1.2
1.3
8.0
u/ml
—
5
38
95
681
1.41
2.60
1.4
1.3
26.8
31.3
iu/l
0.81
85
578
169
1323
1.29
2.60
4.0
3.8
46.4
48.1
%
0.38
164
1307
459
3990
1.18
2.59
1.2
1.2
10.3
13.0
u/ml
0.40
156
1492
32
178
1.81
2.55
1.1
1.1
—
—
—
0
0
32
178
1.81
2.55
1.1
1.1
—
—
—
0
0
582
5165
1.16
2.52
1.3
1.2
2.1
1.5
u/ml
0.35
109
1307
19
88
2.17
2.50
2.2
2.1
1335.8
23277.4
e6/l
0.54
13
50
477
4174
1.17
2.48
1.3
1.3
26.7
38.0
iu/ml
1.51
153
1317
32
181
1.78
2.43
1.1
1.1
—
—
—
0
0
32
181
1.78
2.43
1.1
1.1
—
—
—
0
0
32
181
1.78
2.43
1.1
1.1
—
—
—
0
0
180
1438
1.27
2.39
3.2
3.2
24.7
25.3
mmol/l
1.64
172
1390
39
236
1.66
2.35
1.6
1.6
—
—
—
0
0
102
755
1.36
2.34
1.2
1.2
—
—
—
0
0
9
28
3.22
2.30
2.4
4.4
—
—
—
0
0
26
142
1.84
2.23
2.6
3.9
—
—
—
0
0
102
762
1.35
2.23
1.2
1.2
—
—
—
0
0
220
1820
1.22
2.16
8.2
6.8
24.1
24.6
mmol/l
0.87
206
1694
26
144
1.81
2.14
1.2
1.4
1.3
1.2
nmol/l
0.12
17
113
42
267
1.58
2.11
1.4
1.7
—
1220.0
—
0
8
23
123
1.88
2.11
1.1
1.1
—
—
—
0
0
8
25
3.21
2.09
1.6
1.4
—
—
—
0
0
31
183
1.70
2.07
1.5
1.5
—
—
—
0
0
17
82
2.08
2.06
1.1
1.3
51.4
455.3
ug/l
—
10
40
79
576
1.38
2.03
1.2
1.1
—
—
—
0
0
8
26
3.08
2.01
2.4
2.7
0.5
0.8
u/field
—
8
26
107
820
1.32
2.00
1.4
1.5
285.8
274.9
ug/g
0.24
65
476
188
1548
1.23
1.96
10.3
9.7
—
—
—
0
0
39
250
1.57
1.92
1.2
1.1
—
—
—
0
0
20
106
1.89
1.90
2.0
2.8
66.8
104.5
umol/l
0.58
11
58
52
356
1.47
1.90
1.5
1.4
—
—
—
0
0
25
143
1.75
1.88
2.1
2.5
—
—
—
0
0
755
6943
1.11
1.85
1.6
1.6
1.5
1.4
mmol/l
2.15
648
5765
19
100
1.91
1.85
2.2
2.3
560.4
776.1
e6/l
0.43
13
76
27
159
1.70
1.85
1.6
1.5
—
—
—
0
0
10
222
0.45
1.82
1.4
1.5
—
—
—
0
0
27
160
1.69
1.81
1.6
1.5
—
—
—
0
0
27
161
1.68
1.78
3.3
1.7
—
—
—
0
0
6
18
3.34
1.74
1.7
1.0
—
—
—
0
0
24
141
1.71
1.68
1.2
1.1
—
—
—
0
0
17
90
1.89
1.65
1.6
1.4
17.1
23.2
%
0.52
17
82
22
127
1.74
1.64
1.3
1.8
—
—
—
0
0
80
609
1.32
1.62
2.3
1.4
—
—
—
0
0
10
209
0.48
1.58
1.4
1.4
—
—
—
0
0
10
209
0.48
1.58
1.4
1.4
—
—
—
0
0
10
209
0.48
1.58
1.4
1.4
—
—
—
0
0
10
209
0.48
1.58
1.4
1.4
—
—
—
0
0
2853
28110
1.15
1.56
47.6
22.9
384.2
245.7
e9/l
288.69
2808
27323
13
64
2.04
1.54
1.8
1.6
—
—
—
0
0
79
606
1.31
1.53
2.1
1.8
40.4
42.1
nmol/l
0.28
74
576
2853
28120
1.14
1.50
47.5
22.9
4.4
4.4
e12/l
2.99
2797
27236
209
1791
1.18
1.49
2.7
3.0
125.7
127.9
g/l
0.63
199
1741
2853
28126
1.14
1.47
47.8
23.1
131.0
134.3
g/l
19.47
2826
27654
2853
28126
1.14
1.47
47.6
23.0
8.9
6.8
e9/l
28.33
2799
27243
13
66
1.97
1.43
1.4
1.5
0.5
0.3
ug/l
—
8
35
7
29
2.42
1.39
5.4
5.6
61.3
65.8
ug/min
—
7
24
385
3470
1.12
1.36
5.0
4.7
31.6
33.1
%
2.06
302
2233
658
6104
1.10
1.36
1.6
1.7
21022097.8
26562929.9
pmol/l
0.10
509
4992
25
160
1.57
1.31
1.4
1.5
1.0
1.0
g/l
0.02
25
160
8
34
2.36
1.29
1.5
1.6
—
—
—
0
0
8
35
2.29
1.26
1.0
1.1
—
—
—
0
0
498
5405
0.91
1.23
2.8
3.1
0.8
0.8
ug/l
0.22
340
3719
43
313
1.38
1.22
8.4
6.8
7.5
7.6
mmol/l
0.06
36
265
33
229
1.45
1.21
2.4
2.3
690.4
628.0
ml
0.37
19
149
207
1807
1.16
1.21
2.9
2.2
12.8
12.7
nmol/l
0.00
187
1573
369
3345
1.12
1.20
1.4
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
23
148
1.56
1.20
1.2
1.1
—
—
—
0
0
15
249
0.60
1.17
1.3
1.4
—
—
—
0
0
35
249
1.41
1.14
1.2
1.5
—
—
—
0
0
289
2592
1.13
1.14
1.6
1.8
1.5
1.5
%
0.12
243
2226
163
1408
1.17
1.11
1.3
1.3
192.2
218.6
u/ml
0.22
153
1291
77
620
1.25
1.09
1.2
1.1
20.1
6.0
u/ml
—
7
58
11
59
1.87
1.07
1.1
1.1
—
—
—
0
0
10
52
1.93
1.06
1.1
1.1
—
—
—
0
0
18
113
1.60
1.05
1.1
1.7
2.7
5.9
ug/l
0.66
11
89
25
170
1.47
1.04
1.4
1.8
—
—
—
0
0
85
698
1.22
1.03
3.4
3.2
0.8
0.8
nmol/l
0.41
63
542
26
179
1.46
1.02
1.3
1.2
—
—
—
0
0
48
368
1.31
1.01
1.4
1.9
32305.2
2024.4
u/l
1.00
13
144
123
1049
1.18
1.00
2.4
3.2
414.7
4792.2
u/ml
0.94
105
884
32
231
1.39
0.99
1.0
1.1
—
—
—
0
0
61
486
1.26
0.97
1.2
1.2
252.2
215.2
miu/ml
0.23
19
193
9
50
1.80
0.96
1.0
1.2
—
—
—
0
0
49
382
1.29
0.93
1.2
1.1
—
—
—
0
0
104
881
1.19
0.93
5.4
3.9
4.0
3.9
mmol/l
1.07
99
819
30
217
1.39
0.93
5.1
4.9
47.5
40.9
u/ml
—
10
57
6
28
2.14
0.91
1.7
1.2
—
—
—
0
0
289
2635
1.11
0.89
2.3
2.4
5.2
7.1
ug/l
2.04
229
2294
10
56
1.79
0.87
1.2
1.6
—
—
—
0
0
68
557
1.23
0.87
1.5
1.4
28.0
28.0
e6/l
0.00
54
425
68
557
1.23
0.87
1.6
1.4
947.6
1349.7
e6/l
0.18
57
449
165
1461
1.14
0.85
1.2
1.2
92.6
141.0
iu/ml
1.25
58
521
21
298
0.70
0.85
1.0
1.3
7.9
7.5
mmol/l
0.18
16
217
126
1096
1.16
0.84
1.3
1.3
—
—
—
0
0
32
239
1.34
0.84
1.3
1.3
—
—
—
0
0
11
65
1.69
0.82
1.0
1.2
—
—
—
0
0
6
32
1.88
0.81
1.5
1.2
29.8
36.9
nmol/l
—
6
26
165
1467
1.13
0.81
3.3
2.9
0.3
0.3
e6/l
0.21
160
1436
190
1705
1.12
0.80
2.6
2.4
26.4
23.9
au/ml
—
9
76
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
6
33
1.82
0.79
1.0
1.2
—
—
—
0
0
331
3069
1.09
0.75
3.0
4.0
13.9
22.6
ug/l
0.49
253
2522
719
7529
0.94
0.74
3.8
4.5
22.4
21.8
%
0.47
359
3806
7
40
1.75
0.71
1.4
1.2
—
—
—
0
0
20
143
1.40
0.70
1.2
1.1
—
—
—
0
0
7
41
1.71
0.70
1.4
1.2
—
—
—
0
0
8
49
1.63
0.62
1.0
1.1
—
—
—
0
0
10
152
0.66
0.61
1.5
1.6
—
—
—
0
0
8
53
1.51
0.58
1.1
1.1
—
6.0
—
0
8
6
35
1.72
0.57
1.0
1.2
2.6
1.9
umol/24h
—
6
35
21
158
1.33
0.57
1.0
1.0
—
—
—
0
0
15
207
0.72
0.56
1.0
1.0
888.8
689.2
ng/l
—
10
132
15
206
0.73
0.55
1.0
1.0
38.1
46.9
ng/l
—
10
130
15
206
0.73
0.55
1.0
1.0
277.3
322.7
ng/l
—
10
134
35
284
1.23
0.55
1.2
1.0
3.5
2.2
u/ml
—
9
105
22
168
1.31
0.55
1.8
1.3
3.0
1.3
u/ml
0.27
17
86
79
692
1.15
0.54
1.3
1.2
—
—
—
0
0
9
60
1.50
0.54
1.0
1.2
—
—
—
0
0
6
40
1.50
0.51
1.5
1.3
—
—
—
0
0
11
76
1.45
0.48
1.5
1.2
90.2
109.5
%
0.75
11
66
22
173
1.27
0.46
1.2
1.1
7.5
7.5
nmol/l
—
5
38
21
166
1.27
0.43
1.3
1.3
10.3
12.1
mmol/l
0.64
11
61
21
166
1.27
0.43
1.6
1.8
4.6
10.6
umol/l
0.91
14
106
31
371
0.83
0.42
3.0
4.9
364.6
349.5
umol/l
0.22
24
320
13
173
0.75
0.42
1.3
1.5
—
—
—
0
0
5
33
1.52
0.41
1.4
1.0
—
—
—
0
0
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
341
3252
1.05
0.40
1.4
1.4
—
—
—
0
0
5
34
1.47
0.40
1.2
1.1
—
—
—
0
0
39
334
1.17
0.39
1.1
1.1
—
9.9
—
0
17
14
107
1.31
0.37
1.1
1.2
—
—
—
0
0
8
115
0.69
0.37
1.6
1.3
—
—
—
0
0
11
81
1.36
0.36
1.2
1.1
—
—
—
0
0
60
671
0.89
0.36
1.5
1.6
12097.2
14976.3
e6/l
0.35
45
473
9
71
1.27
0.36
1.0
1.4
10.8
9.1
ug/l
—
9
71
62
691
0.90
0.35
2.1
1.8
—
—
—
0
0
6
43
1.40
0.35
1.5
1.3
50.4
75.2
%
—
6
37
62
687
0.90
0.33
1.8
1.8
—
—
—
0
0
21
173
1.22
0.32
1.6
1.5
—
—
—
0
0
107
1153
0.93
0.32
1.0
1.0
—
—
—
0
0
13
101
1.29
0.31
1.4
1.4
2.8
3.1
mmol/l
0.24
13
90
27
230
1.18
0.31
1.1
1.4
19.9
28.8
u/l
1.14
19
186
8
64
1.25
0.27
1.0
1.0
—
—
—
0
0
9
117
0.77
0.27
1.2
1.4
—
—
—
0
0
9
119
0.76
0.27
1.1
1.5
—
—
—
0
0
19
160
1.19
0.25
1.6
1.2
—
—
—
0
0
9
74
1.22
0.25
1.1
1.1
—
—
—
0
0
9
75
1.20
0.25
1.3
1.1
—
—
—
0
0
9
76
1.18
0.24
1.3
1.1
—
—
—
0
0
12
96
1.25
0.24
1.2
2.0
25.2
103.4
ug/l
0.46
12
85
75
697
1.08
0.23
2.7
2.3
247.1
101.6
ug/min
0.69
43
422
28
246
1.14
0.23
1.9
2.1
3.2
2.1
u/field
0.44
14
90
23
199
1.16
0.23
1.1
1.1
—
3.9
—
0
12
66
611
1.08
0.23
4.1
3.7
28.1
28.6
mg/l
0.04
40
383
5
39
1.28
0.23
1.4
1.5
59.0
44.4
umol/l
—
5
39
68
631
1.08
0.22
2.5
3.3
398.4
757.4
u/ml
0.30
58
580
347
3573
0.97
0.22
8.5
7.5
—
—
—
0
0
18
153
1.18
0.22
2.2
2.1
16.7
180.7
ug/min
—
6
34
548
5600
0.97
0.21
4.2
4.4
1.0
1.0
kg/l
1.02
85
850
37
409
0.90
0.21
1.1
1.1
63.6
97.3
iu/ml
—
7
84
0
11
0.00
0.21
0.0
1.1
—
7.7
—
0
11
0
10
0.00
0.21
0.0
1.3
—
2.6
—
0
10
60
646
0.93
0.20
1.6
1.4
—
—
—
0
0
28
313
0.89
0.20
1.1
1.1
0.1
1.7
u/ml
—
9
125
79
744
1.06
0.19
1.3
1.4
—
—
—
0
0
10
82
1.22
0.17
3.9
2.4
—
—
—
0
0
10
82
1.22
0.17
3.9
2.4
—
—
—
0
0
18
158
1.14
0.16
1.7
1.2
—
—
—
0
0
8
73
1.10
0.15
1.1
1.1
—
—
—
0
0
35
380
0.92
0.15
1.8
1.5
—
—
—
0
0
6
80
0.75
0.15
1.0
1.1
2113.7
1664.7
miu/ml
—
6
80
9
82
1.10
0.15
1.4
1.1
—
—
—
0
0
9
82
1.10
0.15
1.4
1.1
—
—
—
0
0
17
150
1.13
0.14
1.8
1.5
42.1
67.2
pmol/l
—
10
51
27
246
1.10
0.14
1.2
1.5
19.9
29.0
%
0.78
14
152
34
367
0.93
0.14
1.2
1.5
—
—
—
0
0
8
99
0.81
0.13
1.1
1.0
—
—
—
0
0
950
9410
1.01
0.12
4.5
5.1
3.0
3.6
ug/l
0.33
837
8378
861
8691
0.99
0.11
3.1
3.2
7.2
7.3
mmol/l
0.29
713
7196
149
1452
1.03
0.10
1.7
1.9
—
—
—
0
0
5
44
1.14
0.10
1.4
1.5
81.3
123.4
ng/l
—
5
44
135
1315
1.03
0.10
1.7
1.8
—
—
—
0
0
39
369
1.06
0.09
1.9
2.2
14.8
23.4
mg/l
—
5
86
5
64
0.78
0.08
3.4
2.9
—
—
—
0
0
7
67
1.04
0.08
1.0
1.1
—
—
—
0
0
8
78
1.03
0.07
2.0
1.7
—
—
—
0
0
9
85
1.06
0.07
1.1
1.1
—
—
—
0
0
13
142
0.92
0.06
1.1
1.1
0.9
1.2
u/l
—
6
74
11
121
0.91
0.06
1.2
1.3
20.4
24.3
umol/l
0.19
11
115
52
537
0.97
0.06
2.0
1.7
—
—
—
0
0
35
337
1.04
0.04
1.3
1.5
69.2
60.9
%
0.61
20
208
13
138
0.94
0.02
1.1
1.0
—
—
—
0
0
54
550
0.98
0.02
1.3
1.8
0.8
0.8
nmol/l
0.03
45
449
887
8883
1.00
0.01
3.9
4.0
13.9
8.8
mg/mmol
1.55
538
5567
55
543
1.01
0.01
1.3
1.4
—
—
—
0
0
19
184
1.03
0.00
1.3
1.4
1.2
1.2
promille
0.03
12
142
26
254
1.02
0.00
1.8
1.5
—
—
—
0
0
23
226
1.02
0.00
1.7
1.5
0.2
0.3
nmol/l
0.23
17
169
16
158
1.01
0.00
1.4
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
4.1
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
6.8
—
67.0
—
0
6
0
5
0.00
0.00
0.0
1.8
—
1.6
—
0
5
59
590
1.00
0.00
1.3
1.9
2.7
4.6
iu/l
2.22
18
191
0
6
0.00
0.00
0.0
1.0
—
1478.7
—
0
6
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
7
73
0.96
0.00
1.3
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: MYELOPROF – Myeloproliferative diseases
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).